Global Green Inc (GREY:GOGC)

Tuesday, June 12, 2012 | Web News
Global Green, Inc. (OTCBB:GOGC) announced today that the Company has received the final report on the model Efficacy Study conducted on the Company’...
See All Research...
Global Green, Inc. plans to manufacture, market and sell the patented, exclusive, licensed vaccine known as the “Salmogenics Vaccine.” Salmogenics was developed by Nutritional Health Institute Laboratories, LLC (a research affiliate and majority shareholder) to combat Salmonella bacteria in eggs and poultry. The vaccine is currently in the final stage of the USDA approval process. The Company has received approval from FINRA to begin trading publicly on the OTC market and has applied for DTC approval.

Web site: http://www.globalgreeninc.org

Last updated June 12, 2012